Ocugen (OCGN) Current Deferred Revenue (2014 - 2018)
Ocugen (OCGN) posted Current Deferred Revenue of $45000.0 for Q4 2018, down 99.1% on a QoQ basis from $5.0 million in Q3 2018, and up 28.57% year-over-year from $35000.0 in Q4 2017.
Ocugen (OCGN) Current Deferred Revenue (2014 - 2018) Analysis & Trends
Ocugen's Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $45000.0 for Q4 2018.
- Quarterly Current Deferred Revenue rose 28.57% year-over-year to $45000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $45000.0 (up 28.57% YoY) and the FY2018 annual result came in at $45000.0, up 28.57% from the prior year.
- Current Deferred Revenue was $45000.0 for Q4 2018 at Ocugen, down from $5.0 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $7.5 million in Q2 2018 and bottomed at $35000.0 in Q4 2017.
- A 5-year average of $1.1 million and a median of $133000.0 in 2016 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2017 — Current Deferred Revenue slumped 74.26% — and 2018, when it jumped 8620.93%.
- Ocugen's Current Deferred Revenue stood at $219000.0 in 2014, then sank by 42.47% to $126000.0 in 2015, then advanced by 7.94% to $136000.0 in 2016, then slumped by 74.26% to $35000.0 in 2017, then climbed by 28.57% to $45000.0 in 2018.
- Business Quant data shows OCGN's Current Deferred Revenue at $45000.0 in Q4 2018, $5.0 million in Q3 2018, and $7.5 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 45,000.00 |
| Sep 30, 2018 | 5.00 Mn |
| Jun 30, 2018 | 7.50 Mn |
| Mar 31, 2018 | 5.00 Mn |
| Dec 31, 2017 | 35,000.00 |
| Sep 30, 2017 | 60,000.00 |
| Jun 30, 2017 | 86,000.00 |
| Mar 31, 2017 | 110,000.00 |
| Dec 31, 2016 | 136,000.00 |
| Sep 30, 2016 | 133,000.00 |
| Jun 30, 2016 | 131,000.00 |
| Mar 31, 2016 | 128,000.00 |
| Dec 31, 2015 | 126,000.00 |
| Sep 30, 2015 | 225,000.00 |
| Jun 30, 2015 | 223,000.00 |
| Mar 31, 2015 | 224,000.00 |
| Dec 31, 2014 | 219,000.00 |